SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-140479
Filing Date
2022-05-04
Accepted
2022-05-04 16:17:05
Documents
14
Period of Report
2022-05-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d197099d8k.htm   iXBRL 8-K 23658
2 EX-99.1 d197099dex991.htm EX-99.1 15763
6 GRAPHIC g197099dsp1a.jpg GRAPHIC 18088
  Complete submission text file 0001193125-22-140479.txt   195330

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jazz-20220504.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20220504_lab.xml EX-101.LAB 18690
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20220504_pre.xml EX-101.PRE 11693
8 EXTRACTED XBRL INSTANCE DOCUMENT d197099d8k_htm.xml XML 3529
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 22891727
SIC: 2834 Pharmaceutical Preparations